News
Mind Medicine is developing MM120, a fast-acting, single-dose treatment for anxiety and depressive disorders. Read more on ...
Welltica+ on MSN4h
Party Drug Gets Green Light to Treat DepressionA controversial substance once tied to underground rave culture is now being hailed as a breakthrough for depression.
Nerve or neuropathic pain has long been a tricky condition to treat effectively. However, a new study has comprehensively ...
A major international study has provided the most comprehensive evidence to date on treatments for neuropathic pain—defined ...
5d
Discover Magazine on MSNMicrodosing Psychedelics as Treatment Could Increase Flexible ThinkingHowever, more work on just how these compounds rewire the brain will be necessary before they become viable treatments for ...
Dr. Brian Barnett shows the inside of the dosing room at Cleveland Clinic Lutheran where participants in a study looking at ...
If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...
With a lack of real breakthroughs since the 1960s, older methods such as electrical-based therapies are experiencing a revival in psychiatry.
That's why today, ketamine is increasingly being used to treat a variety of illnesses, including depression, anxiety, ...
5d
Study Finds on MSNSingle Psychedelic Dose Shows Cognitive Boost Lasting WeeksLearn how psychedelics can enhance adaptability in the brain, improving learning and memory for conditions like PTSD.
In particular, use of the hallucinogenic substance increased by 44 percent in 2023 among young adults aged between 18 and 29.
4don MSN
Research on high-ventilation breathing practices is limited. Could they work on the brain similar to psychedelics?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results